Global Multiple Myeloma Market to grow at a CAGR of 4.8% and reach $ Global Multiple Myeloma Market to grow at a CAGR o | Page 7

8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AbbVie Inc.
8.3 Ablynx NV
8.4 Acceleron Pharma Inc.
8.5 IGF Oncology LLC.
8.6 ImmunGene Inc.
8.7 Millennium Pharmaceuticals Inc.
8.8 MimiVax LLC
8.9 Mirna Therapeutics
8.10 RedHill Biopharma Ltd.
8.11 Rhizen Pharmaceuticals S.A.
8.12 Terpenoid Therapeutics Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures